Showing results (51-60 of 65,774) with videos related to
Sort By:
Pageof 6,578
Advances in Therapy|October 27, 2019
Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to PatientsLuigino Calzetta, Maria Gabriella Matera, Mario Cazzola, et al.Current Opinion in Pharmacology|December 14, 2020
Prospects for severe asthma treatmentLuigino Calzetta, Maria Gabriella Matera, Angelo Coppola, et al.Expert Opinion on Drug Metabolism & Toxicology|June 3, 2016
Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthmaLuigino Calzetta, Barbara Rinaldi, Mario Cazzola, et al.Expert Opinion on Investigational Drugs|July 5, 2018
Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach?Mario Cazzola, Maria Gakriella Matera, Paola Rogliani, et al.International Journal of Chronic Obstructive Pulmonary Disease|September 16, 2025
Multi-Criteria Decision Analysis of Biologics in Chronic Obstructive Pulmonary DiseaseMaria Gabriella Matera, Luigino Calzetta, Paola Rogliani, et al.Expert Opinion on Drug Safety|June 10, 2016
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysisPaola Rogliani, Luigino Calzetta, Mario Cazzola, et al.Expert Opinion on Drug Metabolism & Toxicology|July 25, 2017
Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthmaMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.Expert Opinion on Drug Metabolism & Toxicology|October 11, 2017
Pharmacogenetic and pharmacogenomic considerations of asthma treatmentMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.Molecular Diagnosis & Therapy|March 2, 2017
The Challenges of Precision Medicine in COPDMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.Expert Opinion on Emerging Drugs|February 17, 2012
Emerging drugs for chronic obstructive pulmonary diseaseMaria Gabriella Matera, Luigino Calzetta, Andrea Segreti, et al.Pageof 6,578